Skip to content

COVID-19 Resources

Access the latest information on COVID-19 for clinical researchers
  • Home
  • About
    • NIH Collaboratory
      • Coordinating Center
      • NIH Collaboratory Trials
      • Core Working Groups
      • Steering Committee
      • Distributed Research Network
      • Our Impact
    • Living Textbook
      • Table of Contents
      • How to Use This Site
  • Resources
    • Data and Resource Sharing
    • Training Resources
    • Tools for Researchers
    • Publications
    • Knowledge Repository
  • Webinar
  • Podcast
  • News
    • News Feed
    • Calendar
    • Subscribe
return to home
Subscribe to Newsletter go to twitter feed go to linkedin go to blue sky feed
Search
NIH Collaboratory
Living Textbook of
Pragmatic Clinical Trials

COVID-19 Resources

Access the latest information on COVID-19 for clinical researchers
home button

Rethinking Clinical Trials

A Living Textbook of Pragmatic Clinical Trials

  • Design
    • What is a Pragmatic Clinical Trial?
    • Decentralized Pragmatic Clinical Trials
    • Developing a Compelling Grant Application
    • Experimental Designs and Randomization Schemes
    • Endpoints and Outcomes
    • Analysis Plan
    • Using Electronic Health Record Data
    • Building Partnerships and Teams to Ensure a Successful Trial
    • Intervention Delivery and Complexity
    • Patient Engagement
  • Data, Tools & Conduct
    • Assessing Feasibility
    • Acquiring Real-World Data
    • Assessing Fitness-for-Use of Real-World Data
    • Study Startup
    • Participant Recruitment
    • Monitoring Intervention Fidelity and Adaptations
    • Patient-Reported Outcomes
    • Clinical Decision Support
    • Mobile Health
    • Electronic Health Records–Based Phenotyping
    • Navigating the Unknown
  • Dissemination & Implementation
    • Data Sharing and Embedded Research
    • Dissemination Approaches for Different Audiences
    • Implementation
    • End-of-Trial Decision-Making
  • Ethics & Regulatory
    • Privacy Considerations
    • Identifying Those Engaged in Research
    • Collateral Findings
    • Consent, Disclosure, and Non-Disclosure
    • Data and Safety Monitoring
    • Ethical Considerations of Data Sharing in Pragmatic Clinical Trials
    • Ethics for AI and ML
    • IRB Responsibilities and Procedures

Choosing Between Cluster and Individual Randomization – ARCHIVED

CHAPTER SECTIONS

Experimental Designs and Randomization Schemes


Section 5

Choosing Between Cluster and Individual Randomization – ARCHIVED

Expand Contributors

Patrick J. Heagerty, PhD
Elizabeth R. DeLong, PhD
For the NIH Health Care Systems Research Collaboratory Biostatistics and Study Design Core

Contributing Editors
Damon M. Seils, MA
Jonathan McCall, MS

Although CRT designs confer certain advantages in conducting PCTs, they are also characterized by significant theoretical limitations and implementation challenges (Torgerson et al 2001), and careful consideration is needed before settling on a particular approach to randomization. The following assessment questions, adapted from Designing Multi-Center Cluster-Randomized Trials: An Introductory Toolkit (2014), may help clarify whether a CRT represents an appropriate design choice for answering a particular research question:

  • Is the phenomenon of interest something that takes place primarily at the level of the individual patient or study participant (for example, response to an experimental drug or comparator)? If so, a traditional RCT design may be most appropriate. However, if the phenomenon of interest affects individual patients but is primarily taking place at a different level (for example, whether implementation of new physician treatment guidelines is yielding better patient outcomes), a CRT design may be more appropriate.
  • Is the proposed intervention delivered at the level of a group or organization rather than an individual study participant? For example, a study that investigated whether adoption of a new treatment guideline affected the efficiency of service provision across hospitals in a health system would lend itself to a cluster design.
  • If individual participants were randomized, would it be difficult for physicians or other clinical staff to modify their approaches or behaviors in ways that avoid contamination? Similarly, is it likely that participants or study staff might have occasion or opportunity to discuss details of the study (“compare notes”) among themselves? If so, a cluster randomized approach may be preferable for ensuring trial validity.

Finally, it is important to consider that any cluster randomized design will introduce an important statistical effect known as clustering. When several participants (a cluster) are subjected to similar circumstances that may differ from those of other clusters, such as patients in the same ward being treated by the same providers, their outcomes can be correlated. (See also "Intraclass Correlation" under Analysis Plan). This important consideration should be addressed both when randomizing and when calculating the required sample size for a given study.

For additional information about design considerations, see Designing With Implementation and Dissemination in Mind.

Previous Section Next Section

SECTIONS

CHAPTER SECTIONS

sections

  1. Introduction – ARCHIVED
  2. Statistical Design Considerations – ARCHIVED
  3. Cluster Randomized Trials – ARCHIVED
  4. Randomization Methods – ARCHIVED
  5. Choosing Between Cluster and Individual Randomization – ARCHIVED
  6. Alternative Cluster Randomized Designs – ARCHIVED
  7. Concealment and Blinding – ARCHIVED
  8. Designing to Avoid Identification Bias – ARCHIVED
  9. Additional Resources – ARCHIVED

Resources

Pragmatic and Group-Randomized Trials in Public Health and Medicine—Part 1. Introduction and Overview
Online course From the NIH Office of Disease Prevention

REFERENCES

back to top

Torgerson DJ. 2001. Contamination in trials: is cluster randomisation the answer? BMJ. 322:355-357. doi:10.1136/bmj.322.7282.355. PMID: 11159665.

back to top


Version History

July 2, 2020: Minor corrections to layout and formatting (changes made by D. Seils).

May 27, 2020: Added Heagerty to the contributors list and reordered the sections of this chapter as part the annual content update (changed made by D. Seils).

May 5, 2020: Added the Resources sidebar as part of the annual content update (changes made by D. Seils).

January 16, 2019: Made nonsubstantive changes to the text as part of the annual content update (changes made by D. Seils).

Published August 25, 2017

current section :

Choosing Between Cluster and Individual Randomization – ARCHIVED

  1. Introduction – ARCHIVED
  2. Statistical Design Considerations – ARCHIVED
  3. Cluster Randomized Trials – ARCHIVED
  4. Randomization Methods – ARCHIVED
  5. Choosing Between Cluster and Individual Randomization – ARCHIVED
  6. Alternative Cluster Randomized Designs – ARCHIVED
  7. Concealment and Blinding – ARCHIVED
  8. Designing to Avoid Identification Bias – ARCHIVED
  9. Additional Resources – ARCHIVED

Citation:

Heagerty PJ, DeLong ER; for the NIH Health Care Systems Research Collaboratory Biostatistics and Study Design Core. Experimental Designs and Randomization Schemes: Choosing Between Cluster and Individual Randomization – ARCHIVED. In: Rethinking Clinical Trials: A Living Textbook of Pragmatic Clinical Trials. Bethesda, MD: NIH Pragmatic Trials Collaboratory. Available at: https://rethinkingclinicaltrials.org/chapters/design/experimental-designs-randomization-schemes-top/considerations-when-choosing-between-a-crt-individual-randomization-designs/. Updated July 9, 2025. DOI: 10.28929/005.

Footer Menu

  • How to Use This Site
  • About NIH Collaboratory
  • Enrollment Reporting
  • Grand Rounds
  • Funding Statement
Link to Twitter Link to LinkedIn Link to Blue Sky Link to NIH Collaboratory email

Reference in this Web site to any specific commercial products, process, service, manufacturer, or company does not constitute its endorsement or recommendation by the U.S. Government or National Institutes of Health (NIH). NIH is not responsible for the contents of any “off-site” Web page referenced from this server.

Log in
Privacy Statement
WordPress is a content management system and should not be used to upload any PHI as it is not an environment for which we exercise oversight, meaning you the author are responsible for the content you post. Please use this system accordingly. Site Map